TransCode Therapeutics gets Australia and Japan patent application allowances
TransCode Therapeutics says patent applications in Australia and Japan were allowed, supporting its RNA platform for targeted cancer therapy and immune modulation.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.